Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aldizem
2. Cardil
3. Cardizem
4. Crd 401
5. Crd-401
6. Crd401
7. Dilacor
8. Dilacor Xr
9. Dilren
10. Diltiazem
11. Diltiazem Malate
12. Dilzem
13. Tiazac
1. 33286-22-5
2. Diltiazem Hcl
3. Cardizem
4. Dilzem
5. Dilzene
6. Masdil
7. (+)-cis-diltiazem Hydrochloride
8. Tiazac
9. Crd-401
10. Altiazem
11. Deltazen
12. Diladel
13. Dilpral
14. Dilrene
15. Tildiem
16. Adizem
17. Herbesser
18. Dilacor
19. Lacerol
20. Zilden
21. Mono-tildiem
22. Bi-tildiem
23. Cardizem Cd
24. Cardizem La
25. Cardil
26. Dilren
27. Dilthiazem Hydrochloride
28. Diltiazem (hydrochloride)
29. Diltzac
30. Cartia
31. Rg 83606
32. (2s,3s)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl Acetate Hydrochloride
33. Taztia
34. Diltiazem Hcl (tiazac)
35. 103532-26-9
36. Mls000028432
37. Olh94387te
38. Rg 83606 Hcl
39. Chebi:645509
40. Anoheal
41. Nsc-759576
42. (+)-5-(2-(dimethylamino)ethyl)-cis-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Acetate (ester) Monohydrochloride
43. (2s,3s)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate Hydrochloride
44. [(2s,3s)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] Acetate;hydrochloride
45. 38411-61-9
46. Dilzicardin
47. Anginyl
48. Angitil
49. Angizem
50. Britiazim
51. Calcicard
52. Calnurs
53. Cardiazem
54. Cirilen
55. Citizen
56. Clarute
57. Corazet
58. Dilatam
59. Dilatame
60. Dilcard
61. Dilgard
62. Dilicardin
63. Diltahexal
64. Diltelan
65. Diltiasyn
66. Diltikor
67. Diltime
68. Dinisor
69. Dodexen
70. Entrydil
71. Farmabes
72. Gadoserin
73. Helsibon
74. Incoril
75. Kaltiazen
76. Levozem
77. Longazem
78. Lytelsen
79. Metazem
80. Miocardie
81. Oxycardil
82. Pazeadin
83. Pentilzeno
84. Poltiazem
85. Presoken
86. Rg-83606
87. Smr000058375
88. Tilazem
89. Trumsal
90. Ziruvate
91. Bruzem
92. Carzem
93. Diatal
94. Dilfar
95. Dilsal
96. Diltam
97. Diltan
98. Doclis
99. Dyalac
100. Etizen
101. Etyzen
102. Herben
103. Kardil
104. Myonil
105. Slozen
106. Tiadil
107. Tiaves
108. Ubicor
109. Zildem
110. Carex
111. Coras
112. Dazil
113. Dilem
114. Dilso
115. Hesor
116. Tazem
117. Apo-diltiazem
118. Iski
119. Altiazem Retard
120. Cardizem Retard
121. Diltiazem Merck
122. Diltiazem Stada
123. Diltiazem Verla
124. Diltiazem-mepha
125. 33286-22-5 (hcl)
126. Cardil Retard
127. Dil-sonaramia
128. Diltiazem-isis
129. Dilzem Retard
130. Dinisor Retard
131. Myonil Retard
132. Novo-diltazem
133. Syn-diltiazem
134. Tildiem Retard
135. Diltiazem Basics
136. Diltiazem-cophar
137. Mfcd00069252
138. Uni Masdil
139. Wl Diltiazem
140. Altiazem Rr
141. Cardizem Sr
142. Diltiazem Awd
143. Diltiazem Gnr
144. Diltiazem Msd
145. Diltiazem-gry
146. Cirilen Ap
147. Diltiazem Henning
148. Diltiazem Upsa
149. Tildiem Cr
150. Tildiem La
151. Adizem-cd
152. Cartia Xt
153. Diltan Sr
154. Diltiazem Eu Rho
155. Dilzem Rr
156. Taztia Xt
157. Viazem Sr
158. Viazem Xl
159. Herbesser 60
160. (2s-cis)-3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Monohydrochloride
161. [(2s,3s)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] Acetate;hydron;chloride
162. 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, Monohydrochloride, (+)-cis-
163. Herbesser 90 Sr
164. Tilazem 90
165. Diltiazem Chloridrate
166. Dilatam 120
167. Tilazem As 60
168. Tilazem As 90
169. Dilzereal 90 Retard
170. Herbesser 180 Sr
171. Dolizem
172. Iski-90 Sr
173. Diltia Xt
174. Dilt-xr
175. Dodexen A.p.
176. Presokin A. P.
177. Mk-793
178. Crd 401
179. Tiazac Extended Release
180. Sr-01000003042
181. Einecs 251-443-3
182. Dilacor Xr Extended Release Capsules
183. Unii-olh94387te
184. Milptin
185. Carzen
186. Slozem
187. Crd401
188. Dilthiazem Hcl
189. Dov Diltiazem
190. Uni-masdil
191. Cardizem Xl
192. Tiazac Xc
193. Cardizem (tn)
194. Prestwick_176
195. Acetate Hydrochloride
196. Einecs 253-918-0
197. Dilacor Xr (tn)
198. Cartia Xt (tn)
199. Opera_id_79
200. Diltiazem Hydrochloride [usan:usp:jan]
201. Dilt-cd (tn)
202. (+)-5-(2-(dimethylamino)ethyl)-cis-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Acetate Ester Monohydrochloride
203. 2-[(2s,3s)-3-(acetyloxy)-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2h)-yl]-n,n-dimethylethanaminium Chloride
204. Chembl1697
205. Diltiazem Hydrochloride,(s)
206. Schembl15457
207. Mls001148257
208. Mls002222179
209. Diltiazem Hcl [vandf]
210. (+)-cis-diltiazem Hydrochlorid
211. Diltiazem For System Suitability
212. Dtxsid8040147
213. Amy8835
214. Slv-324
215. Ven-307
216. Hms1568k10
217. (2s-trans)-diltiazem Hydrochloride
218. Act02682
219. Bcp13814
220. Diltiazem Hydrochloride [mi]
221. Tox21_500327
222. Bnp-32762
223. Diltiazem Hydrochloride (jp17/usp)
224. Diltiazem Hydrochloride [jan]
225. S1865
226. 3,3,3-phosphinylidynetrispropionamide
227. Diltiazem Hydrochloride [usan]
228. Akos015961992
229. Ccg-220134
230. Ccg-221631
231. Diltiazem Hydrochloride [mart.]
232. Diltiazem Hydrochloride [vandf]
233. Ks-5089
234. Lp00327
235. Nc00558
236. Nsc 759576
237. Diltiazem Hydrochloride [usp-rs]
238. Diltiazem Hydrochloride [who-dd]
239. Tetrahydrobenzo[b][1,4]thiazepin-3-yl
240. Ncgc00093768-01
241. Ncgc00261012-01
242. (2s,3s)-(+)-3-acetoxy-2,3-dihydro-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Hydrochloride
243. 1,5-benzothiazepin-4(5h)-one, 2,3-dihydro-3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-, Monohydrochloride, Cis-(+)-
244. Ac-15189
245. Ac-32469
246. As-13703
247. Bd166408
248. Cis-(1)-3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Monohydrochloride
249. Hy-14656
250. (+)-cis-diltiazem Hydrochloride, >/=98%
251. (2s,3s)-5-(2-(dimethylamino)ethyl)-2
252. D3662
253. Diltiazem Hydrochloride [ep Impurity]
254. Diltiazem Hydrochloride [orange Book]
255. Eu-0100327
256. Sw196487-3
257. Diltiazem Hydrochloride [ep Monograph]
258. Bim-0050315.0001
259. D 2521
260. D00616
261. Diltiazem Hydrochloride [usp Monograph]
262. Diltiazem, Hydrochloride - Cas 33286-22-5
263. F20448
264. M01693
265. (+)-cis-diltiazem Hydrochloride, >=99% (hplc)
266. 286d225
267. Sr-01000075327
268. J-019130
269. Sr-01000003042-2
270. Sr-01000003042-4
271. Sr-01000075327-1
272. Q27105183
273. Diltiazem Hydrochloride 1.0 Mg/ml In Acetonitrile (as Free Base)
274. Diltiazem Hydrochloride, European Pharmacopoeia (ep) Reference Standard
275. Diltiazem Hydrochloride, United States Pharmacopeia (usp) Reference Standard
276. Diltiazem For System Suitability, European Pharmacopoeia (ep) Reference Standard
277. (2s,3s)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl Acetate Hcl
278. (2s,3s)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-ylacetatehydrochloride
279. (2s-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one Hydrochloride
280. 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, Hydrochloride (1:1), (2s,3s)-
281. Acetic Acid (2s,3s)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl Ester; Hydrochloride
282. Cis-(+)-3-acetoxy-2,3-dihydro-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one Hydrochloride
283. Diltiazem Hydrochloride Solution, 1.0 Mg/ml In Acetonitrile (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 451.0 g/mol |
|---|---|
| Molecular Formula | C22H27ClN2O4S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 450.1380062 g/mol |
| Monoisotopic Mass | 450.1380062 g/mol |
| Topological Polar Surface Area | 84.4 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 565 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 16 | |
|---|---|
| Drug Name | Cardizem |
| PubMed Health | Diltiazem |
| Drug Classes | Antianginal, Antihypertensive, Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | CARDIZEM (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 60mg; 30mg; 90mg; 120mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 2 of 16 | |
|---|---|
| Drug Name | Cardizem cd |
| Drug Label | CARDIZEM (diltiazem hydrochloride) is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2, 3-dihydro-2-(4-metho... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 120mg; 360mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 3 of 16 | |
|---|---|
| Drug Name | Cardizem la |
| PubMed Health | Diltiazem |
| Drug Classes | Antianginal, Antihypertensive, Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | CARDIZEM LA (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 420mg; 120mg; 360mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 4 of 16 | |
|---|---|
| Drug Name | Cartia xt |
| PubMed Health | Diltiazem (Intravenous route) |
| Drug Classes | Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-methoxyphen... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 120mg; 240mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl |
| 5 of 16 | |
|---|---|
| Drug Name | Dilacor xr |
| Drug Label | DILACOR XR (diltiazem hydrochloride, USP) is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 120mg; 240mg |
| Market Status | Prescription |
| Company | Watson Labs |
| 6 of 16 | |
|---|---|
| Drug Name | Diltiazem hydrochloride |
| Drug Label | Diltiazem is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet, extended release; Injectable; Tablet; Capsule, extended release |
| Route | injection; Injection; Oral |
| Strength | 300mg; 50mg/10ml; 180mg; 100mg/vial; 5mg/ml; 30mg; 60mg; 90mg; 125mg/25ml; 420mg; 120mg; 10mg/ml; 360mg; 240mg |
| Market Status | Prescription |
| Company | Intl Medication; Bedford; Valeant Intl; Hospira; Hikma Maple; Actavis Labs Fl; Teva; Apotex; Hikma Farmaceutica; Teva Pharms Usa; Sandoz; Sun Pharma Global; Par Pharm; Mylan; Actavis; Akorn |
| 7 of 16 | |
|---|---|
| Drug Name | Taztia xt |
| Drug Label | TAZTIA XT brand ofDILTIAZEM HYDROCHLORIDE EXTENDED-RELEASECAPSULES USP(ONCE-A-DAY DOSAGE)Rx Only... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 120mg; 360mg; 300mg; 240mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl |
| 8 of 16 | |
|---|---|
| Drug Name | Tiazac |
| Drug Label | Tiazac (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, mon... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 420mg; 120mg; 360mg; 300mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 9 of 16 | |
|---|---|
| Drug Name | Cardizem |
| PubMed Health | Diltiazem |
| Drug Classes | Antianginal, Antihypertensive, Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | CARDIZEM (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 60mg; 30mg; 90mg; 120mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 10 of 16 | |
|---|---|
| Drug Name | Cardizem cd |
| Drug Label | CARDIZEM (diltiazem hydrochloride) is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2, 3-dihydro-2-(4-metho... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 120mg; 360mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 11 of 16 | |
|---|---|
| Drug Name | Cardizem la |
| PubMed Health | Diltiazem |
| Drug Classes | Antianginal, Antihypertensive, Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | CARDIZEM LA (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 420mg; 120mg; 360mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
| 12 of 16 | |
|---|---|
| Drug Name | Cartia xt |
| PubMed Health | Diltiazem (Intravenous route) |
| Drug Classes | Benzothiazepine, Calcium Channel Blocker, Cardiovascular Agent |
| Drug Label | Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-methoxyphen... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 300mg; 180mg; 120mg; 240mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl |
| 13 of 16 | |
|---|---|
| Drug Name | Dilacor xr |
| Drug Label | DILACOR XR (diltiazem hydrochloride, USP) is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 120mg; 240mg |
| Market Status | Prescription |
| Company | Watson Labs |
| 14 of 16 | |
|---|---|
| Drug Name | Diltiazem hydrochloride |
| Drug Label | Diltiazem is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Tablet, extended release; Injectable; Tablet; Capsule, extended release |
| Route | injection; Injection; Oral |
| Strength | 300mg; 50mg/10ml; 180mg; 100mg/vial; 5mg/ml; 30mg; 60mg; 90mg; 125mg/25ml; 420mg; 120mg; 10mg/ml; 360mg; 240mg |
| Market Status | Prescription |
| Company | Intl Medication; Bedford; Valeant Intl; Hospira; Hikma Maple; Actavis Labs Fl; Teva; Apotex; Hikma Farmaceutica; Teva Pharms Usa; Sandoz; Sun Pharma Global; Par Pharm; Mylan; Actavis; Akorn |
| 15 of 16 | |
|---|---|
| Drug Name | Taztia xt |
| Drug Label | TAZTIA XT brand ofDILTIAZEM HYDROCHLORIDE EXTENDED-RELEASECAPSULES USP(ONCE-A-DAY DOSAGE)Rx Only... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 120mg; 360mg; 300mg; 240mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl |
| 16 of 16 | |
|---|---|
| Drug Name | Tiazac |
| Drug Label | Tiazac (diltiazem hydrochloride) is a calcium ion cellular influx inhibitor (slow channel blocker). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, mon... |
| Active Ingredient | Diltiazem hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 180mg; 420mg; 120mg; 360mg; 300mg; 240mg |
| Market Status | Prescription |
| Company | Valeant Intl |
Treatment of chronic anal fissure
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
With Fermion, start the journey of your innovative API.
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-01
Pay. Date : 2016-12-29
DMF Number : 5717
Submission : 1985-02-06
Status : Active
Type : II
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-29
Pay. Date : 2012-11-08
DMF Number : 7239
Submission : 1987-11-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-03-18
Pay. Date : 2021-03-15
DMF Number : 6761
Submission : 1987-01-05
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-18
Pay. Date : 2012-12-12
DMF Number : 7600
Submission : 1988-07-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6686
Submission : 1986-11-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7887
Submission : 1989-02-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3059
Submission : 1977-11-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7540
Submission : 1988-06-16
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7240
Submission : 1987-10-26
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-05-29
Application Number : 20092
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-05-29
Application Number : 20092
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-05-29
Application Number : 20092
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 1997-08-26
Application Number : 74894
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2022-05-05
Application Number : 215775
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 90MG
Packaging :
Approval Date : 2022-05-05
Application Number : 215775
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG
Packaging :
Approval Date : 2022-05-05
Application Number : 215775
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CARDIZEM LA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2003-02-06
Application Number : 21392
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 360MG
Packaging :
Approval Date : 2006-09-12
Application Number : 76563
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DILTIAZEM HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 90MG
Packaging :
Approval Date : 2022-09-23
Application Number : 216521
Regulatory Info : RX
Registration Country : USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 120MG
USFDA APPLICATION NUMBER - 18602
DOSAGE - TABLET;ORAL - 30MG
USFDA APPLICATION NUMBER - 18602
DOSAGE - TABLET;ORAL - 60MG
USFDA APPLICATION NUMBER - 18602
DOSAGE - TABLET;ORAL - 90MG
USFDA APPLICATION NUMBER - 18602
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120MG
USFDA APPLICATION NUMBER - 20062
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180MG
USFDA APPLICATION NUMBER - 20062
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240MG
USFDA APPLICATION NUMBER - 20062
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 300...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 300MG
USFDA APPLICATION NUMBER - 20062
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 360...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 360MG
USFDA APPLICATION NUMBER - 20062
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20092
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20092
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20092
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 120MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 180MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 240MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 300...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 300MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 360...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 360MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 420...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 420MG
USFDA APPLICATION NUMBER - 20401
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 120M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 120MG
USFDA APPLICATION NUMBER - 21392
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 180M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 180MG
USFDA APPLICATION NUMBER - 21392
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 240M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 240MG
USFDA APPLICATION NUMBER - 21392
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300MG
USFDA APPLICATION NUMBER - 21392
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 360M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 360MG
USFDA APPLICATION NUMBER - 21392
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 420M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 420MG
USFDA APPLICATION NUMBER - 21392
Related Excipient Companies
Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vertellus
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Direct Compression
Thickeners and Stabilizers
Solubilizers
Granulation
Taste Masking
Film Formers & Plasticizers
Parenteral
Lubricants & Glidants
Co-Processed Excipients
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Topical
Emulsifying Agents
Empty Capsules
Rheology Modifiers
API Stability Enhancers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Diltiazem Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diltiazem Hydrochloride, including repackagers and relabelers. The FDA regulates Diltiazem Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diltiazem Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diltiazem Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diltiazem Hydrochloride supplier is an individual or a company that provides Diltiazem Hydrochloride active pharmaceutical ingredient (API) or Diltiazem Hydrochloride finished formulations upon request. The Diltiazem Hydrochloride suppliers may include Diltiazem Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Diltiazem Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diltiazem Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Diltiazem Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Diltiazem Hydrochloride DMFs exist exist since differing nations have different regulations, such as Diltiazem Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diltiazem Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Diltiazem Hydrochloride USDMF includes data on Diltiazem Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diltiazem Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diltiazem Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Diltiazem Hydrochloride Drug Master File in Japan (Diltiazem Hydrochloride JDMF) empowers Diltiazem Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Diltiazem Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Diltiazem Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Diltiazem Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diltiazem Hydrochloride Drug Master File in Korea (Diltiazem Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diltiazem Hydrochloride. The MFDS reviews the Diltiazem Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Diltiazem Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diltiazem Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diltiazem Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diltiazem Hydrochloride suppliers with KDMF on PharmaCompass.
A Diltiazem Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Diltiazem Hydrochloride Certificate of Suitability (COS). The purpose of a Diltiazem Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diltiazem Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diltiazem Hydrochloride to their clients by showing that a Diltiazem Hydrochloride CEP has been issued for it. The manufacturer submits a Diltiazem Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diltiazem Hydrochloride CEP holder for the record. Additionally, the data presented in the Diltiazem Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diltiazem Hydrochloride DMF.
A Diltiazem Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diltiazem Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diltiazem Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Diltiazem Hydrochloride written confirmation (Diltiazem Hydrochloride WC) is an official document issued by a regulatory agency to a Diltiazem Hydrochloride manufacturer, verifying that the manufacturing facility of a Diltiazem Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diltiazem Hydrochloride APIs or Diltiazem Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Diltiazem Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Diltiazem Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diltiazem Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diltiazem Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diltiazem Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diltiazem Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diltiazem Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diltiazem Hydrochloride suppliers with NDC on PharmaCompass.
Diltiazem Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diltiazem Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diltiazem Hydrochloride GMP manufacturer or Diltiazem Hydrochloride GMP API supplier for your needs.
A Diltiazem Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Diltiazem Hydrochloride's compliance with Diltiazem Hydrochloride specifications and serves as a tool for batch-level quality control.
Diltiazem Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Diltiazem Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diltiazem Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Diltiazem Hydrochloride EP), Diltiazem Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diltiazem Hydrochloride USP).
LOOKING FOR A SUPPLIER?
